155 related articles for article (PubMed ID: 27312008)
1. Inhibition of Plasmodium falciparum Hsp90 Contributes to the Antimalarial Activities of Aminoalcohol-carbazoles.
Wang T; Mäser P; Picard D
J Med Chem; 2016 Jul; 59(13):6344-52. PubMed ID: 27312008
[TBL] [Abstract][Full Text] [Related]
2. A repurposing strategy identifies novel synergistic inhibitors of Plasmodium falciparum heat shock protein 90.
Shahinas D; Liang M; Datti A; Pillai DR
J Med Chem; 2010 May; 53(9):3552-7. PubMed ID: 20349996
[TBL] [Abstract][Full Text] [Related]
3. Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors.
Wang T; Bisson WH; Mäser P; Scapozza L; Picard D
J Med Chem; 2014 Mar; 57(6):2524-35. PubMed ID: 24580531
[TBL] [Abstract][Full Text] [Related]
4. Ursolic acid acetate and iso-mukaadial acetate bind to Plasmodium falciparum Hsp90, abrogating its chaperone function in vitro.
Nndwammbi AAT; Dongola TH; Shonhai A; Mokoena F; Pooe OJ; Simelane MBC
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5179-5192. PubMed ID: 38252299
[TBL] [Abstract][Full Text] [Related]
5. In silico identification and evaluation of potential interaction of Azadirachta indica phytochemicals with Plasmodium falciparum heat shock protein 90.
Daniyan MO; Ojo OT
J Mol Graph Model; 2019 Mar; 87():144-164. PubMed ID: 30544005
[TBL] [Abstract][Full Text] [Related]
6. Identification of Plasmodium falciparum heat shock 90 inhibitors via molecular docking.
Everson N; Bach J; Hammill JT; Falade MO; Rice AL; Guy RK; Eagon S
Bioorg Med Chem Lett; 2021 Mar; 35():127818. PubMed ID: 33513390
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of heat shock protein 90 from Plasmodium falciparum: molecular modelling approach to rational drug design against malaria.
Kumar R; Pavithra SR; Tatu U
J Biosci; 2007 Apr; 32(3):531-6. PubMed ID: 17536172
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial activity of tetrahydro-β-carbolines targeting the ATP binding pocket of the Plasmodium falciparum heat shock 90 protein.
Eagon S; Hammill JT; Bach J; Everson N; Sisley TA; Walls MJ; Durham S; Pillai DR; Falade MO; Rice AL; Kimball JJ; Lazaro H; DiBernardo C; Kiplin Guy R
Bioorg Med Chem Lett; 2020 Nov; 30(21):127502. PubMed ID: 32822760
[TBL] [Abstract][Full Text] [Related]
9. Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome.
Mansfield CR; Quan B; Chirgwin ME; Eduful B; Hughes PF; Neveu G; Sylvester K; Ryan DH; Kafsack BFC; Haystead TAJ; Leahy JW; Fitzgerald MC; Derbyshire ER
Cell Chem Biol; 2024 Apr; 31(4):729-742.e13. PubMed ID: 38492573
[TBL] [Abstract][Full Text] [Related]
10. Co-chaperones of Hsp90 in Plasmodium falciparum and their concerted roles in cellular regulation.
Chua CS; Low H; Sim TS
Parasitology; 2014 Aug; 141(9):1177-91. PubMed ID: 24560171
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes.
Banumathy G; Singh V; Pavithra SR; Tatu U
J Biol Chem; 2003 May; 278(20):18336-45. PubMed ID: 12584193
[TBL] [Abstract][Full Text] [Related]
12. A purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90).
Shahinas D; Folefoc A; Taldone T; Chiosis G; Crandall I; Pillai DR
PLoS One; 2013; 8(9):e75446. PubMed ID: 24098696
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug.
Pallavi R; Roy N; Nageshan RK; Talukdar P; Pavithra SR; Reddy R; Venketesh S; Kumar R; Gupta AK; Singh RK; Yadav SC; Tatu U
J Biol Chem; 2010 Dec; 285(49):37964-75. PubMed ID: 20837488
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of Plasmodium falciparum co-chaperone Aha1 supports its interaction with and regulation of Hsp90 in the malaria parasite.
Chua CS; Low H; Lehming N; Sim TS
Int J Biochem Cell Biol; 2012 Jan; 44(1):233-45. PubMed ID: 22100910
[TBL] [Abstract][Full Text] [Related]
15. Antimalarial activity of a new family of analogues of manzamine A.
Winkler JD; Londregan AT; Hamann MT
Org Lett; 2006 Jun; 8(12):2591-4. PubMed ID: 16737321
[TBL] [Abstract][Full Text] [Related]
16. Targeting heat shock protein 90 for malaria.
Ramdhave AS; Patel D; Ramya I; Nandave M; Kharkar PS
Mini Rev Med Chem; 2013 Nov; 13(13):1903-20. PubMed ID: 24070209
[TBL] [Abstract][Full Text] [Related]
17. Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity.
Posfai D; Eubanks AL; Keim AI; Lu KY; Wang GZ; Hughes PF; Kato N; Haystead TA; Derbyshire ER
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339390
[TBL] [Abstract][Full Text] [Related]
18. Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin.
Shahinas D; Macmullin G; Benedict C; Crandall I; Pillai DR
Antimicrob Agents Chemother; 2012 Aug; 56(8):4207-13. PubMed ID: 22615284
[TBL] [Abstract][Full Text] [Related]
19. Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition.
Mbaba M; de la Mare JA; Sterrenberg JN; Kajewole D; Maharaj S; Edkins AL; Isaacs M; Hoppe HC; Khanye SD
J Biol Inorg Chem; 2019 Mar; 24(2):139-149. PubMed ID: 30542925
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the
Stofberg ML; Caillet C; de Villiers M; Zininga T
Cells; 2021 Oct; 10(11):. PubMed ID: 34831072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
